Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on February 11, 2009
J Am Soc Nephrol 20: 730-741, 2009
© 2009 American Society of Nephrology
doi: 10.1681/ASN.2008020142

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
ASN.2008020142v1
20/4/730    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Advani, A.
Right arrow Articles by Kelly, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Advani, A.
Right arrow Articles by Kelly, D. J.

BASIC RESEARCH

Expression, Localization, and Function of the Thioredoxin System in Diabetic Nephropathy

Andrew Advani*, Richard E. Gilbert*, Kerri Thai*, Renae M. Gow{dagger}, Robyn G. Langham{dagger}, Alison J. Cox{dagger}, Kim A. Connelly*, Yuan Zhang{dagger}, Andrew M. Herzenberg{ddagger}, Per Knud Christensen§, Carol A. Pollock||, Weier Qi{dagger}, Sih Min Tan{dagger}, Hans-Henrik Parving and Darren J. Kelly{dagger}

* Keenan Research Centre of the Li Ka Shing Knowledge Institute, St. Michael's Hospital, and {ddagger} Department of Pathology, University Health Network, Toronto, Ontario, Canada; {dagger} Department of Medicine, St. Vincent's Hospital, University of Melbourne, Melbourne, Victoria, and || Department of Medicine, Royal North Shore Hospital, New South Wales, Australia; and § Steno Diabetes Center, Gentofte, and Department of Medical Endocrinology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark

Correspondence: Dr. Richard E. Gilbert, St. Michael's Hospital, 61 Queen Street East, Toronto, Ontario, Canada, M5C 2T2. Phone: 416-867-3747; Fax: 416-867-7495; E-mail: richard.gilbert{at}utoronto.ca

Received for publication February 6, 2008. Accepted for publication October 20, 2008.

Excessive reactive oxygen species play a key role in the pathogenesis of diabetic nephropathy, but to what extent these result from increased generation, impaired antioxidant systems, or both is incompletely understood. Here, we report the expression, localization, and activity of the antioxidant thioredoxin and its endogenous inhibitor thioredoxin interacting protein (TxnIP) in vivo and in vitro. In normal human and rat kidneys, expression of TxnIP mRNA and protein was most abundant in the glomeruli and distal nephron (distal convoluted tubule and collecting ducts). In contrast, thioredoxin mRNA and protein localized to the renal cortex, particularly within the proximal tubules and to a lesser extent in the distal nephron. Induction of diabetes in rats increased expression of TxnIP but not thioredoxin mRNA. Kidneys from patients with diabetic nephropathy had significantly higher levels of TxnIP than control kidneys, but thioredoxin expression did not differ. In vitro, high glucose increased TxnIP expression in mesangial, NRK (proximal tubule), and MDCK (distal tubule/collecting duct) cells, and decreased the expression of thioredoxin in mesangial and MDCK cells. Knockdown of TxnIP with small interference RNA suggested that TxnIP mediates the glucose-induced impairment of thioredoxin activity. Knockdown of TxnIP also abrogated both glucose-induced 3H-proline incorporation (a marker of collagen production) and oxidative stress. Taken together, these findings suggest that impaired thiol reductive capacity contributes to the generation of reactive oxygen species in diabetes in a site- and cell-specific manner.




This article has been cited by other articles:


Home page
HypertensionHome page
A. Advani, D. J. Kelly, A. J. Cox, K. E. White, S. L. Advani, K. Thai, K. A. Connelly, D. Yuen, J. Trogadis, A. M. Herzenberg, et al.
The (Pro)Renin Receptor: Site-Specific and Functional Linkage to the Vacuolar H+-ATPase in the Kidney
Hypertension, August 1, 2009; 54(2): 261 - 269.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP